Monoclonal Antibody (AFH1) Immunoreactive on Morphologically Abnormal Basal Melanocytes Within Dysplastic Nevi, Nevocellular Nevus Nests, and Melanoma
- 1 April 1988
- journal article
- research article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 90 (4), 452-458
- https://doi.org/10.1111/1523-1747.ep12460896
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Clinical diagnosis of dysplastic melanocytic nevi: A clinicopathologic correlationJournal of the American Academy of Dermatology, 1986
- Human Monoclonal Antibodies That Distinguish Cutaneous Malignant Melanomas from Benign Nevi in Fixed Tissue SectionsJournal of Investigative Dermatology, 1986
- Monoclonal Antibodies Selected to Discriminate Between Malignant Melanomas and Nevocellular NeviJournal of Investigative Dermatology, 1985
- Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomasJournal of the American Academy of Dermatology, 1983
- Localization of Melanoma-Associated Antigen p97 in Cultured Human Melanoma, as Visualized by Light and Electron MicroscopyJournal of Investigative Dermatology, 1983
- Distribution and molecular characterization of a cell‐surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodiesInternational Journal of Cancer, 1981
- Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies.Proceedings of the National Academy of Sciences, 1980
- Production of monoclonal antibodies: Strategy and tacticsJournal of Immunological Methods, 1980
- Cell surface antigens of human melanoma identified by monoclonal antibody.Proceedings of the National Academy of Sciences, 1979
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975